The Endocrine Society today issued a Clinical Practice Guideline (CPG) advising against using testosterone therapy in healthy women. Although the FDA approved testosterone therapy for the treatment of diseases affecting the testes, pituitary and hypothalamus, it has not been approved for treating age-associated decrease in testosterone levels. The U.S. National Institute on Aging is also anticipated to release the results of research on the safety of testosterone. The study involved nearly 800 older men with low testosterone and symptoms related to this ailment, including anti aging supplement (click the following page
) physical and sexual dysfunction. The research is expected to shed more light on the security of testosterone treatment since the men's heart health was carefully tracked.
Research has shown that testosterone deficiency is related to several significant health problems such as metabolic syndrome, obesity, diabetes, and bone fractures Guys who meet medical standards for treatment should receive therapy. The truth is, your testosterone levels have likely been slowly falling for some time, a decline that typically begins around age 30.
And many women have a knee jerk feeling that any hormone treatment
can raise their risk of breast cancer. Nevertheless, clinical studies demonstrate that testosterone not only doesn't increase a woman's risk of breast cancer , it may play a key role in warding off the disease. Glaser thinks this will probably stay the status quo for some time, given the prohibitive cost of conducting the long-term safety studies needed to gain completer FDA acceptance.